Numerous studies have confirmed that SNHG16 acts as a tumour suppressor during CRC development by regulating tumour cell invasiveness and metastasis in vivo and in vitro (Qi et al., 2015; Li Y. et al., 2019). Here, SNHG16 is linked to neoplasm.